Free Trial

AtriCure (ATRC) Competitors

AtriCure logo
$31.50 +1.33 (+4.41%)
Closing price 07/25/2025 04:00 PM Eastern
Extended Trading
$31.54 +0.05 (+0.14%)
As of 07/25/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ATRC vs. TFX, ITGR, ATEC, IART, SRDX, OFIX, ANGO, ARAY, RMTI, and RSLS

Should you be buying AtriCure stock or one of its competitors? The main competitors of AtriCure include Teleflex (TFX), Integer (ITGR), Alphatec (ATEC), Integra LifeSciences (IART), Surmodics (SRDX), Orthofix Medical (OFIX), AngioDynamics (ANGO), Accuray (ARAY), Rockwell Medical (RMTI), and ReShape Lifesciences (RSLS). These companies are all part of the "health care equipment" industry.

AtriCure vs. Its Competitors

AtriCure (NASDAQ:ATRC) and Teleflex (NYSE:TFX) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, dividends, institutional ownership, valuation, analyst recommendations, media sentiment, profitability and earnings.

Teleflex has higher revenue and earnings than AtriCure. AtriCure is trading at a lower price-to-earnings ratio than Teleflex, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AtriCure$465.31M3.35-$44.70M-$0.81-38.89
Teleflex$3.05B1.70$69.68M$3.1736.99

AtriCure presently has a consensus target price of $50.67, indicating a potential upside of 60.85%. Teleflex has a consensus target price of $159.63, indicating a potential upside of 36.14%. Given AtriCure's stronger consensus rating and higher probable upside, research analysts clearly believe AtriCure is more favorable than Teleflex.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AtriCure
0 Sell rating(s)
0 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
3.00
Teleflex
1 Sell rating(s)
8 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.09

99.1% of AtriCure shares are held by institutional investors. Comparatively, 95.6% of Teleflex shares are held by institutional investors. 3.5% of AtriCure shares are held by company insiders. Comparatively, 1.4% of Teleflex shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, Teleflex had 6 more articles in the media than AtriCure. MarketBeat recorded 11 mentions for Teleflex and 5 mentions for AtriCure. AtriCure's average media sentiment score of 1.14 beat Teleflex's score of 1.00 indicating that AtriCure is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
AtriCure
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Teleflex
8 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

AtriCure has a beta of 1.56, indicating that its share price is 56% more volatile than the S&P 500. Comparatively, Teleflex has a beta of 1.08, indicating that its share price is 8% more volatile than the S&P 500.

Teleflex has a net margin of 4.96% compared to AtriCure's net margin of -7.95%. Teleflex's return on equity of 14.73% beat AtriCure's return on equity.

Company Net Margins Return on Equity Return on Assets
AtriCure-7.95% -5.68% -4.34%
Teleflex 4.96%14.73%8.79%

Summary

AtriCure and Teleflex tied by winning 8 of the 16 factors compared between the two stocks.

Get AtriCure News Delivered to You Automatically

Sign up to receive the latest news and ratings for ATRC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ATRC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ATRC vs. The Competition

MetricAtriCureMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$1.49B$10.55B$5.70B$9.50B
Dividend YieldN/A2.00%4.60%4.01%
P/E Ratio-38.8917.0728.1020.05
Price / Sales3.3529.18429.3789.38
Price / CashN/A23.0336.2258.56
Price / Book3.333.698.665.87
Net Income-$44.70M$234.77M$3.25B$258.55M
7 Day Performance7.66%6.32%4.22%3.73%
1 Month Performance-4.20%7.94%10.51%11.75%
1 Year Performance42.53%-13.57%34.40%18.03%

AtriCure Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ATRC
AtriCure
3.3316 of 5 stars
$31.50
+4.4%
$50.67
+60.8%
+33.9%$1.49B$465.31M-38.891,300News Coverage
Positive News
Upcoming Earnings
TFX
Teleflex
4.8676 of 5 stars
$115.78
-0.5%
$164.63
+42.2%
-47.3%$5.12B$3.01B36.5214,100Positive News
Upcoming Earnings
ITGR
Integer
3.3893 of 5 stars
$119.61
-0.3%
$145.00
+21.2%
-6.5%$4.17B$1.72B56.6911,000Trending News
Earnings Report
Analyst Forecast
ATEC
Alphatec
3.9107 of 5 stars
$10.91
-0.7%
$17.89
+64.0%
-0.5%$1.59B$642.27M-9.49700News Coverage
Positive News
Upcoming Earnings
IART
Integra LifeSciences
4.1407 of 5 stars
$12.21
-3.0%
$18.63
+52.5%
-58.4%$948.84M$1.61B-32.134,396News Coverage
Upcoming Earnings
SRDX
Surmodics
4.0254 of 5 stars
$31.39
+1.7%
$43.00
+37.0%
-13.4%$448.88M$126.08M-22.58450News Coverage
Upcoming Earnings
OFIX
Orthofix Medical
2.7408 of 5 stars
$10.98
-0.6%
$21.50
+95.8%
-31.7%$430.20M$799.49M-2.981,616
ANGO
AngioDynamics
3.9515 of 5 stars
$9.63
+3.3%
$14.00
+45.4%
+22.8%$391.05M$283.32M-9.53760High Trading Volume
ARAY
Accuray
3.1256 of 5 stars
$1.36
flat
N/A-27.3%$140.10M$465.25M0.001,040News Coverage
Positive News
RMTI
Rockwell Medical
3.9965 of 5 stars
$1.11
-1.8%
$4.00
+260.4%
-42.2%$37.93M$97.73M0.00300Positive News
RSLS
ReShape Lifesciences
0.4256 of 5 stars
$2.39
+0.4%
N/A-99.2%$5.71M$8.01M-0.0150Positive News

Related Companies and Tools


This page (NASDAQ:ATRC) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners